课题基金 / 基金详情

MIDDLE EAR EFFUSION LEVELS OF CEFPODOXIME AFTER ORAL SUSPENSION ADMINISTRATION

MIDDLE EAR EFFUSION LEVELS OF CEFPODOXIME AFTER ORAL SUSPENSION ADMINISTRATION
口服混悬液给药后头孢泊肟的中耳积液水平
批准号：
5219042
负责人：
DAVID Peter MCCORMICK
金额：
$0.0万
依托单位：
--
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/5219042
关键词：
antibacterial agents bacterial disease child (0-11) clinical research clinical trials drug screening /evaluation ear disorder chemotherapy exudate /transudate human subject human therapy evaluation microorganism disease chemotherapy oral administration otitis media pediatric pharmacology pharmacokinetics

项目摘要

项目成果

DAVID Peter MCCORMICK的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The purpose of this study is to determine the penetration of cefpodoxime into middle ear effusion of pediatric patients with acute otitis media following administration of Vantin Oral Suspension as 5 mg/kg (200 mg maximum) twice daily or 10mg/kg once daily. This study provides more information on the effectiveness of cefalospoons in the treatment of bacterial otitis media. We have been requested by UpJohn to continue recruitment beyond the 15 patients for whom we had originally contracted. All patients are followed up 10-12 days after the beginning of treatment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
OTITIS MEDIA: PARENT EDUCATION TO AVOID ANTIBIOTIC USE
Otitis Media: Parent Education to Avoid Antibiotic Use
OTITIS MEDIA: PARENT EDUCATION TO AVOID ANTIBIOTIC USE
OTITIS MEDIA: PARENT EDUCATION TO AVOID ANTIBIOTIC USE
海外基金